The human ciliopathy protein RSG1 links the CPLANE complex to transition zone architecture. Read more about The human ciliopathy protein RSG1 links the CPLANE complex to transition zone architecture.
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer. Read more about Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.
Selfish mutations promote age-associated erosion of mtDNA integrity in mammals. Read more about Selfish mutations promote age-associated erosion of mtDNA integrity in mammals.
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity. Read more about Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression. Read more about Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression.
Author Correction: Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy. Read more about Author Correction: Multi-institutional atlas of brain metastases informs spatial modeling for precision imaging and personalized therapy.
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma. Read more about CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma.
FOXA2 promotes metastatic competence in small cell lung cancer. Read more about FOXA2 promotes metastatic competence in small cell lung cancer.
Massively parallel reporter assays and mouse transgenic assays provide correlated and complementary information about neuronal enhancer activity. Read more about Massively parallel reporter assays and mouse transgenic assays provide correlated and complementary information about neuronal enhancer activity.
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma. Read more about FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.
